Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MORETreatment for subclinical infectious bovine mastitis in lactating cows due to Streptococcus agalactiae and penicillin-sensitive Staphylococcus aureus.
LEARN MOREIntranasal vaccine for healthy cattle, 1 week or older against IBR virus, BRSV, PI3, Mannheimia haemolytica and Pasteurella multocida.
LEARN MORE